167 related articles for article (PubMed ID: 19572149)
1. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.
Zhao C; Gong L; Li W; Chen L
J Cancer Res Clin Oncol; 2010 Jan; 136(1):9-16. PubMed ID: 19572149
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
3. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
4. PLK1 Is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting β-catenin degradation in esophageal squamous cell carcinoma.
Lin DC; Zhang Y; Pan QJ; Yang H; Shi ZZ; Xie ZH; Wang BS; Hao JJ; Zhang TT; Xu X; Zhan QM; Wang MR
Clin Cancer Res; 2011 Jul; 17(13):4285-95. PubMed ID: 21610149
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.
Zhang G; Zhang Z; Liu Z
Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma.
Tong T; Zhong Y; Kong J; Dong L; Song Y; Fu M; Liu Z; Wang M; Guo L; Lu S; Wu M; Zhan Q
Clin Cancer Res; 2004 Nov; 10(21):7304-10. PubMed ID: 15534106
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.
Feng YB; Lin DC; Shi ZZ; Wang XC; Shen XM; Zhang Y; Du XL; Luo ML; Xu X; Han YL; Cai Y; Zhang ZQ; Zhan QM; Wang MR
Int J Cancer; 2009 Feb; 124(3):578-88. PubMed ID: 19004025
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
10. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
11. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
12. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
13. miR‑210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1.
Li C; Zhou X; Wang Y; Jing S; Yang C; Sun G; Liu Q; Cheng Y; Wang L
Mol Med Rep; 2014 Oct; 10(4):2099-104. PubMed ID: 25069478
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
15. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
Gu MM; Li M; Gao D; Liu LH; Lang Y; Yang SM; Ou H; Huang B; Zhou PK; Shang ZF
Toxicol Appl Pharmacol; 2018 Jun; 348():76-84. PubMed ID: 29679654
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma.
Tang S; Qin J; Liu W; Zheng X; Wu X; Xu H; Qiao L; Fan Q; Zeng W; Jiang M
Mol Med Rep; 2015 Jun; 11(6):4291-6. PubMed ID: 25634618
[TBL] [Abstract][Full Text] [Related]
18. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.
Li X; Suo J; Shao S; Xue L; Chen W; Dong L; Shi J; Fu M; Lu N; Zhan Q; Tong T
PLoS One; 2014; 9(3):e90958. PubMed ID: 24608342
[TBL] [Abstract][Full Text] [Related]
20. Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma.
Shiozaki A; Nako Y; Ichikawa D; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
World J Gastroenterol; 2014 Jun; 20(22):6844-59. PubMed ID: 24944475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
